The original instrument was prepared by Christine Arbo Peck. The following digest,
which does not constitute a part of the legislative instrument, was prepared by Ann
S. Brown.
DIGEST
SB 282 Reengrossed 2018 Regular Session Mills
Proposed law requires certain health insurance issuers to notify enrollees that they are subject to an
excess consumer cost burden when they are charged more for a prescription drug than their insurer
pays or would pay after considering drug rebates from the drug manufacturer into the total cost of
the drug.
Proposed law requires certain health insurance issuers to certify to the commissioner of insurance
that they passed on to the consumer at least 50% of the rebates received from drug manufacturers.
Proposed law provides that in making this certification all information given to the commissioner
shall be confidential.
Proposed law provides for enforcement against a health insurance issuer's license for failure to
comply with proposed law, or providing a false certification.
Effective August 1, 2018.
(Amends R.S. 44:4.1(B)(11); adds R.S. 22:976)
Summary of Amendments Adopted by Senate
Senate Floor Amendments to engrossed bill
1. Removes provision applying proposed law to pharmacy benefit managers
participating in the Medicaid program.
2. Makes a technical change.
3. Changes definition of "excess consumer cost burden".